You are here: Home » News-CM » Equities » Hot Pursuit
Business Standard

Shree Ganesh Remedies board approves rights issue

Capital Market 

The drug maker's board has approved the proposal for raising upto Rs 45 crore through rights issue of equity shares.

The board of Shree Ganesh Remedies at its meeting held on 19 November 2021, approved the proposal for raising of funds by issuance of equity shares of the company for an amount not exceeding Rs 45 crore by way of a rights issue to the eligible equity shareholders. The record date will be determined and notified subsequently.

The detailed terms in relation to the rights issue, including the issue price, rights entitlement ratio, record date, timing and terms of payment will be determined in due course.

On a consolidated basis, net profit of Shree Ganesh Remedies declined 2.27% to Rs 3.02 crore on 47.31% rise in net sales to Rs 16.97 crore in Q2 September 2021 over Q2 September 2020.

Shree Ganesh Remedies is an Indian pharmaceuticals company. Its core activities consist of manufacturing & export of pharmaceutical intermediates & fine chemicals and research & development.

Shares of Shree Ganesh Remedies rose 1.03% to settle at Rs 344.80 on Thursday. The domestic stock market was shut on Friday on account of Guru Nanak Jayanti.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Sat, November 20 2021. 09:38 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU